ClinicalTrials.govpublic full text
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
hyperlipidemia, primary hyperlipidemia or mixed dyslipidemia, high risk of cardiovascular events, multiple cardiovascular disease risk factors., interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 995144
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.